Semaglutide has emerged as a novel treatment for type 2 diabetes. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to secrete more insulin and reducing glucagon https://abelesea482387.win-blog.com/16383149/comprehending-semaglutide-a-comprehensive-guide